In our study, both the univariate and multivariate analysis showed that B7-H3 is an independent factor associated with poor PFS and OS whereas the clinicopathologic variables (age, sex, tumor size, TKIs, and mutation subtypes) have no correlation with poor survival of anti-EGFR therapy. Here, EGFR is linked to neoplasm.